Extracellular Vesicles in Hematological Malignancies: Communicators for Resistance and Treatment
Journal: Haematology International Journal (HIJ) (Vol.6, No. 2)Publication Date: 2022-07-12
Authors : Bahmei A; Tamaddon G;
Page : 1-7
Keywords : Drug resistance; Exosome therapy; Exosome measuring; Extracellular vesicles; Personalized medicine;
Abstract
Extracellular vehicles (EVs), the secret messengers of a cell, are cell-derived signaling vesicles present in most human fluids. They have been recently discovered and are known as signaling particles or a type of dialogue between cells known as microvesicles, exosomes, and apoptotic bodies. The EVs can carry different types of cargo that can be delivered to recipient cells and lead to changes in the phenotype of a cell which might be useful or harmful. Here, we discuss what these busybody cells are, how they are formed, and what they can do in drug resistance or how they have been used as a therapeutic tool in several hematological malignancies. These miniature molecules are a fascinating new field of research. They can be made artificially as therapeutic agents in the era of personalized medicine for overcoming the relapse of hematological malignancies.
Other Latest Articles
- Apoptosis Induction of Ganoderic Acid-A by Downregulating miR- 125b and miR-365a-3p in Nalm-6 cells
- Changes in Loc285758 Expression in Response to Cytarabine- Based Treatment in Patients with Acute Myeloid Leukemia
- Blood Group ABO, Placental Malaria Parasitization and Pregnancy Outcome in Munuki Primary health Centre in South Sudan
- Circulating Megakaryocytes in Peripheral Blood: A Clue to Satisfactory Platelet Recovery Post Induction Chemotherapy in Acute Myeloid Leukemia
- Adaptation of ISTH Guidelines on Vaccine Induced Thrombocytopenic Thrombosis to Clinical Practice and Analysis of Patient Cases
Last modified: 2023-07-06 20:40:25